Purchase Order W81K0024P0169
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$1.3M
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Diasorin Inc.
Ultimate Awardee
Diasorin S.P.A.
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Stillwater, MN 55082, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract award, valued at $85,364.46, was issued by the Defense Health Agency (DHA) to the foreign-owned, for-profit company Diasorin Inc. The contract is for the provision of reagents under a delivery order, with a period of performance through September 30, 2025. This award is not associated with any set-aside designation. Diasorin Inc. is a subsidiary of the Italy-based medical diagnostics firm Diasorin S.P.A. The company has a strong track record as a federal contractor, providing...
The U.S. Defense Health Agency awarded a firm fixed-price purchase order contract to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company, for immunochemistry reagents and supplies. The $929,972 contract has an ultimate completion date of October 31, 2025. This sole-source award is not set-aside and is justified under the authority of FAR 6.302-1 as the analyzers and reagents are proprietary to Diasorin. The contract provides for the continued lease of two Diasorin LIAISON XL...
This federal contract award, valued at $172,834.00, was issued by the Defense Health Agency to Diasorin Inc., a foreign-owned, for-profit company that specializes in diagnostic testing equipment, assays, reagents, and related services for the medical industry. The contract is a firm fixed-price Blanket Purchase Agreement (BPA) call to provide reagents, equipment, and peripherals. There was no set-aside used for this acquisition. Diasorin Inc. has a proven track record as a federal contractor,...
This federal contract award is for the provision of reagents for laboratory testing by the Defense Health Agency, a defense agency under the Department of Defense. The contract was awarded to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company based in Stillwater, Minnesota. The contract is a Blanket Purchase Agreement (BPA) Call with a firm fixed price and a ceiling value of $18,690.00. The performance period ends on September 30, 2025. The contract does not have a...
This is a $120,500.00 firm fixed price purchase order awarded by the Department of the Air Force Materiel Command Lifecycle Management Center to Diasorin Inc., a foreign-owned for-profit organization that provides medical diagnostic products and services. The contract is for the delivery of Diasorin reagents and does not have a set-aside designation. Diasorin has supported various federal healthcare programs, including supplying reagents for Liaison XL immunoassay analyzers to the Department...
This federal contract award for $350,000 was issued by the Defense Health Agency (DHA) to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of reagents and closely associated functions, with an ultimate completion date of September 30, 2017. This award is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has a significant presence in the U.S....
This is a definitive contract awarded by the Medical Command of the Department of Defense (DoD) to Diasorin Inc., a foreign-owned, for-profit company that specializes in diagnostic testing equipment, assays, reagents, and related services for the medical industry. The contract, valued at $485,345.04, is for the provision of immunochemistry reagents and has a completion date of October 31, 2018. Diasorin Inc. has a proven track record as a federal contractor, supplying critical diagnostic...
This federal contract award, valued at $19,190.00, was issued by the Defense Health Agency to Diasorin Inc., a foreign-owned, for-profit medical diagnostics company. The contract is for the provision of REAGENT KITS and has an ultimate completion date of September 30, 2025. The contract type is a Blanket Purchase Agreement (BPA) Call with a Firm Fixed Price pricing structure. Diasorin Inc. is a subsidiary of the Italian-based Diasorin S.P.A. and has established a significant presence in the U.S....
This federal contract award is for reagents for laboratory testing, awarded by the Defense Health Agency to Diasorin Inc., a foreign-owned, for-profit company that specializes in producing diagnostic testing equipment, assays, reagents, and related services. The contract has a ceiling value of $19,650.00 and is a Delivery Order under the Multiple Award Schedule (MAS) contract vehicle. No set-aside was used for this award. Diasorin Inc. is a subsidiary of the parent company Diasorin S.P.A., an...
This is a $444,490.00 firm fixed price purchase order contract awarded by the Department of the Army Medical Command to Diasorin Inc., a foreign-owned for-profit company, for the provision of immunochemistry reagents and supplies. The contract has no set-aside designation and was awarded on April 3, 2018 with a completion date of October 31, 2020. Diasorin is a major supplier of diagnostic testing equipment and assays to federal agencies, including the Departments of Veterans Affairs (VA),...